For centuries we鈥檝e been using chemicals to improve health, but taking pills seems so 20th century. Join five scientists on the cutting-edge of pharmaceutical research and hear about the latest in gene therapy, cancer treatment and more. Get a sneak peek at the drugs of the future.
Ijeoma Uchegbu is a professor of Pharmaceutical Nanoscience at UCL. Her research focuses on designing drugs that can cross the blood-brain barrier. She won the Royal Pharmaceutical Society's Pharmaceutical Scientist of the Year Award in 2012
Catherine Tuleu is a professor of Paediatric Pharmaceutics at UCL. The main focus of her research concerns drug delivery systems for neonates, infants and children.
Sejal Ranmai is Director of Formulation at Intract Pharma, a science-driven licensing and product development company specialising in gastrointestinal models and state-of-the-art formulation technologies for development of advanced therapeutics.
Stephen Hart is a professor in Molecular Genetics at UCL. His research focuses on developing gene therapies for cardiovascular and respiratory disease, as well as cancer.
Waja Al-Jamal is a reader in the School of Pharmacy at Queen Mary Uninversity of London. Currently, her research focuses on developing smart vectors for delivering a broad range of therapeutic agents, and to fabricate multifunctional nanoparticles to target cancer and other diseases.
The event will take place at The Royal Institution. Doors will open at approximately 6.30pm, with a prompt start at 7.00pm. There will be time for questions after the talk.
Latecomers will be admitted to the gallery.
Ijeoma Uchegbu is a professor of Pharmaceutical Nanoscience at UCL. Her research focuses on designing drugs that can cross the blood-brain barrier. She won the Royal Pharmaceutical Society's Pharmaceutical Scientist of the Year Award in 2012
Catherine Tuleu is a professor of Paediatric Pharmaceutics at UCL. The main focus of her research concerns drug delivery systems for neonates, infants and children.
Sejal Ranmai is Director of Formulation at Intract Pharma, a science-driven licensing and product development company specialising in gastrointestinal models and state-of-the-art formulation technologies for development of advanced therapeutics.
Stephen Hart is a professor in Molecular Genetics at UCL. His research focuses on developing gene therapies for cardiovascular and respiratory disease, as well as cancer.
Waja Al-Jamal is a reader in the School of Pharmacy at Queen Mary Uninversity of London. Currently, her research focuses on developing smart vectors for delivering a broad range of therapeutic agents, and to fabricate multifunctional nanoparticles to target cancer and other diseases.
The event will take place at The Royal Institution. Doors will open at approximately 6.30pm, with a prompt start at 7.00pm. There will be time for questions after the talk.
Latecomers will be admitted to the gallery.
